Generics

After having led for 10 years, Makov is retiring as Sun Pharma's chairman and member of the board.

Mayne Pharma anticipates the commercial launch of Haloette ring by early 2023.

Metrics Contract Services provides a broad range of services, from drug development to commercial manufacturing, from its facility in Greenville, N.C.

Autor has biopharmaceutical industry expertise in quality, regulatory and policy.

​​​​​​​Cimerli is the only biosimilar approved for all five Lucentis indications.

With the acquisition, ANI said it expects to launch four generic products in 2023.

Jevtana is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.

Lumify is an over-the-counter eyedrop that works to relieve redness of the eye due to minor eye irritations.